Mablon Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 11-01-2025
- Paid Up Capital ₹ 0.10 M
as on 11-01-2025
- Company Age 11 Year, 3 Months
- Last Filing with ROC 31 Mar 2019
- Revenue 244.10%
(FY 2019)
- Profit 95.51%
(FY 2019)
- Ebitda 108.81%
(FY 2019)
- Net Worth -1.98%
(FY 2019)
- Total Assets -39.80%
(FY 2019)
About Mablon Biotech
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ashish Dubey and Vijayan Barnam serve as directors at the Company.
- CIN/LLPIN
U74120MH2013PTC248873
- Company No.
248873
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Oct 2013
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Mablon Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashish Dubey  | Director | 04-Oct-2013 | Current |
| Vijayan Barnam | Director | 05-Nov-2016 | Current |
Financial Performance of Mablon Biotech.
Mablon Biotech Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 244.1% increase. The company also saw a substantial improvement in profitability, with a 95.51% increase in profit. The company's net worth dipped by a decrease of 1.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mablon Biotech?
In 2019, Mablon Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mablon Biotech?
Unlock and access historical data on people associated with Mablon Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mablon Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mablon Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
